STEPHANIE KAISER: Open Payments
NPI 1689033722 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,021 in 104 payments from 14 companies in 2025. Trend: 2023 $87 · 2024 $2,026 · 2025 $2,021
Food & beverage: $2,012Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 37 | $484 |
| UCB, Inc. | 19 | $396 |
| Organon LLC | 8 | $287 |
| ABBVIE INC. | 14 | $202 |
| Galderma Laboratories, L.P. | 9 | $162 |
| Janssen Scientific Affairs, LLC | 1 | $122 |
| Janssen Biotech, Inc. | 4 | $97 |
| GENZYME CORPORATION | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
Products named: COSENTYX, Bimzelx, VTAMA, TREMFYA, NEMLUVIO, SKYRIZI, DUPIXENT, RINVOQ.
Industry payments across NY — which companies pay providers there.
